Moshe Grunspan

Moshe Grunspan is an accomplished professional in the field of medical affairs with extensive experience in oncology. Currently serving as the Head of Medical Affairs Oncology at AbbVie since October 2017, Moshe has successfully built and managed a medical affairs team, launched three oncology products/indications, and established strong collaboration with various departments. Prior to this role, Moshe held the position of Medical Advisor, leading strategies for CLL, AML, and MM, and achieved significant market success with Venetoclax. Moshe's earlier experience includes serving as an MSL at Novartis Oncology, where Moshe was instrumental in the reimbursement of treatments for melanoma, as well as a PhD student at the Weizmann Institute of Science, where Moshe developed new genetic engineering technologies. Moshe holds a PhD in Genetics and Developmental Biology, an MSc in Biochemistry and Molecular Biology, and a BSc in Biotechnology from the Weizmann Institute of Science and Bar-Ilan University.